dacarbazine has been researched along with Uveal Neoplasms in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 11 (40.74) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, SE; Baurain, JF; Butler, MO; Carvajal, RD; Curti, B; Demidov, L; Dummer, R; Gastaud, L; Goodall, H; Hamid, O; Hassel, JC; Holland, C; Joshua, AM; Kirkwood, JM; Mauch, C; Milhem, M; Nathan, P; Ochsenreither, S; Orloff, M; Piperno-Neumann, S; Piulats, JM; Rutkowski, P; Sacco, JJ; Salama, AKS; Schlaak, M; Shoushtari, AN; Sullivan, RJ; Yushak, M | 1 |
| Chen, P; Cun, B; Guo, Y; Li, X; Luo, N; Yang, C; Yang, Y | 1 |
| Chen, H; Fei, X; Huang, Q; Ji, X; Jiang, D; Meng, X; Qin, R; Sun, F; Wang, A; Wang, Z; Xie, X; Zhao, Y | 1 |
| Barone, C; Blasi, MA; Cassano, A; Dadduzio, V; Pagliara, M; Quirino, M; Rossi, E; Schinzari, G | 1 |
| Barker, P; Berking, C; Carvajal, RD; Chapman, PB; Chmielowski, B; Clemett, D; Cocquyt, V; Evans, TRJ; Frank, S; Gastaud, L; Ghiorghiu, D; Joshua, AM; Kapiteijn, E; Kilgour, E; Lai, Z; Linette, G; Lovick, S; Mariani, G; Nathan, P; Piperno-Neumann, S; Piulats, JM; Rodrigues, MJ; Schachter, J; Schwartz, GK; Shoushtari, AN; Spratt, S; Wolter, P | 1 |
| Achberger, S; Aldrich, W; Binkley, E; Rybicki, L; Singh, A; Triozzi, PL | 1 |
| Abramson, DH; Albertini, MR; Ambrosini, G; Ancell, K; Bluth, M; Carvajal, RD; Chapman, PB; Dickson, MA; Doyle, A; Erinjeri, J; Flynn, PJ; Gajewski, TF; Hedvat, C; Joshua, AM; Kudchadkar, RR; Lao, CD; Lawson, DH; Lewis, K; Linette, GP; Lutzky, J; Marr, B; Milhem, MM; Panageas, KS; Quevedo, JF; Sato, T; Schwartz, GK; Sosman, JA; Wolchok, JD | 1 |
| Carvajal, RD; Mann, H; Nathan, PD; Schwartz, GK; Smith, I | 1 |
| Asselain, B; Bidard, FC; Cassoux, N; Decaudin, D; Diallo, A; Etienne-Grimaldi, MC; Mariani, P; Piperno-Neumann, S; Plancher, C; Rodrigues, M; Servois, V | 1 |
| Bedikian, AY; Hwu, P; Hwu, WJ; Johnson, MM; Kim, K; McIntyre, S; Papadopoulos, N; Warneke, CL | 1 |
| Aldrich, W; Dombos, C; Triozzi, PL | 1 |
| Al-Jamal, RT; Eskelin, S; Kivelä, T; Pyrhönen, S | 1 |
| Asselain, B; Barillot, E; Bessard, MA; Couturier, J; Dahmani, A; Decaudin, D; Desjardins, L; Donnadieu, MH; Gentien, D; Lantz, O; Laurent, C; Mariani, P; Némati, F; Péguillet, I; Piperno-Neumann, S; Plancher, C; Reyes, C; Robert, D; Roman-Roman, S; Sastre-Garau, X; Saule, S | 1 |
| Dianov, GL; Digweed, M; Eich, M; Kaina, B; Roos, WP | 1 |
| Cun, B; Fan, X; Ge, S; Jia, R; Song, X; Wang, H; Zhao, X | 1 |
| Achberger, S; Aldrich, W; Borden, EC; Grane, R; Singh, AD; Triozzi, PL | 1 |
| Eskelin, S; Hahka-Kemppinen, M; Kivelä, T; Muhonen, T; Nikkanen, V; Pyrhönen, S; Summanen, P; Tarkkanen, A | 1 |
| Camp, R; Hemming, AW; Lind, DS | 1 |
| Ake Hofer, P; Andersson, R; Henriksson, R; Riklund-Ahlström, K | 1 |
| Gore, M; Hahka-Kemppinen, M; Hansson, J; Humblet, Y; Kivelä, T; Kloke, O; Kruit, WH; Kumpulainen, E; Parvinen, LM; Pyrhönen, S; Suciu, S; Vuoristo, MS | 1 |
| Grange, JD; Kodjikian, L; Rivoire, M | 1 |
| Baur, A; Berger, TG; Dieckmann, D; Efferth, T; Funk, JO; Schuler, G; Schultz, ES | 1 |
| Butt, M; Eswar, CV; Gillis, P; Marshall, E; O'Neill, PA | 1 |
| Berd, D; De Potter, P; Mastrangelo, MJ; Nathan, FE; Sato, T; Shield, JA; Shields, CL | 1 |
| Albert, DM; Chappell, R; Darjatmoko, SR; Howes, KA; Koop, BA; Lokken, JM; Mangold, G; Steeves, RA; Syed, NA; Wallow, IH; Windle, JJ | 1 |
1 review(s) available for dacarbazine and Uveal Neoplasms
| Article | Year |
|---|---|
Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Databases, Factual; Disease-Free Survival; Female; Humans; Interferon-alpha; Interleukin-2; Male; Melanoma; Neoplasm Metastasis; Retrospective Studies; Skin Neoplasms; Survival Rate; Uveal Neoplasms; Vinblastine | 2008 |
11 trial(s) available for dacarbazine and Uveal Neoplasms
| Article | Year |
|---|---|
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cytokine Release Syndrome; Dacarbazine; Exanthema; Female; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Recombinant Fusion Proteins; Survival Analysis; Uveal Neoplasms | 2021 |
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study.
Topics: Cisplatin; Dacarbazine; Disease-Free Survival; Female; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Uveal Neoplasms; Vinblastine | 2017 |
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dacarbazine; Double-Blind Method; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Placebos; Progression-Free Survival; Uveal Neoplasms | 2018 |
A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Chemotherapy, Adjuvant; Dacarbazine; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Melanoma; Middle Aged; Prospective Studies; Survival Rate; Uveal Neoplasms; Young Adult | 2020 |
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Benzimidazoles; Dacarbazine; Disease Progression; Female; Humans; Male; Melanoma; Middle Aged; Survival Analysis; Temozolomide; Treatment Outcome; Uveal Neoplasms | 2014 |
Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Uveal Neoplasms | 2015 |
The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon.
Topics: Angiogenic Proteins; Cell Movement; Dacarbazine; Endothelial Cells; Humans; Interferon alpha-2; Interferon-alpha; Melanoma; MicroRNAs; Neovascularization, Pathologic; Recombinant Proteins; Uveal Neoplasms | 2012 |
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Female; Humans; Injections, Intravenous; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome; Uveal Neoplasms; Vincristine | 2002 |
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Feasibility Studies; Female; Humans; Interferon alpha-2; Interferon-alpha; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Recombinant Proteins; Treatment Outcome; Uveal Neoplasms; Vincristine | 2003 |
A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prospective Studies; Thrombocytopenia; Uveal Neoplasms | 2006 |
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Interferon alpha-2; Interferon-alpha; Lomustine; Lung Diseases; Male; Melanoma; Middle Aged; Recombinant Proteins; Uveal Neoplasms; Vincristine | 1997 |
15 other study(ies) available for dacarbazine and Uveal Neoplasms
| Article | Year |
|---|---|
Ubiquitination and degradation of MGMT by TRIM72 increases the sensitivity of uveal melanoma cells to Dacarbazine treatment.
Topics: Adult; Cell Line, Tumor; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Melanoma; Tripartite Motif Proteins; Tumor Suppressor Proteins; Ubiquitination; Uveal Neoplasms | 2022 |
Proteomics analysis: inhibiting the expression of P62 protein by chloroquine combined with dacarbazine can reduce the malignant progression of uveal melanoma.
Topics: Animals; Cell Line, Tumor; Chloroquine; Dacarbazine; Humans; Melanoma; Mice; Mice, Nude; Proteomics; Tumor Microenvironment; Uveal Neoplasms | 2022 |
Selumetinib shows promise in metastatic uveal melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Clinical Trials, Phase II as Topic; Dacarbazine; Disease-Free Survival; Eye Neoplasms; Humans; Melanoma; Neoplasm Metastasis; Temozolomide; Uveal Neoplasms | 2013 |
Uveal melanoma therapy on the horizon?
Topics: Antineoplastic Agents, Alkylating; Benzimidazoles; Dacarbazine; Female; Humans; Male; Melanoma; Uveal Neoplasms | 2014 |
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Male; Melanoma; Middle Aged; Perfusion Imaging; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome; Uveal Neoplasms; Vascular Endothelial Growth Factor A | 2016 |
Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Humans; Imatinib Mesylate; Melanoma; Mice; Piperazines; Pyrimidines; Temozolomide; Uveal Neoplasms; Xenograft Model Antitumor Assays | 2008 |
Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheter Ablation; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Humans; Immunotherapy; Interferon Type I; Liver Neoplasms; Lomustine; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Prognosis; Recombinant Proteins; Treatment Outcome; Uveal Neoplasms; Vincristine | 2009 |
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Dacarbazine; Female; Gene Expression Profiling; Humans; In Situ Hybridization, Fluorescence; Male; Melanoma; Mice; Mice, SCID; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Oligonucleotide Array Sequence Analysis; Organophosphorus Compounds; Polymorphism, Single Nucleotide; Temozolomide; Tumor Cells, Cultured; Uveal Neoplasms; Xenograft Model Antitumor Assays | 2010 |
Nijmegen breakage syndrome protein (NBN) causes resistance to methylating anticancer drugs such as temozolomide.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Caspase 7; Cell Cycle Proteins; Cell Line, Transformed; Cell Line, Tumor; Dacarbazine; DNA Methylation; Drug Resistance, Neoplasm; Fibroblasts; Guanine; Homozygote; Humans; Melanoma; Methylnitronitrosoguanidine; Mutagens; Mutation; Necrosis; Nijmegen Breakage Syndrome; Nuclear Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Temozolomide; Uveal Neoplasms | 2010 |
Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block.
Topics: Adenoviridae; Antineoplastic Agents, Alkylating; Apoptosis; Cell Cycle; Cell Line, Tumor; Combined Modality Therapy; Cytopathogenic Effect, Viral; Dacarbazine; Drug Synergism; Humans; Melanoma; Oncolytic Virotherapy; Oncolytic Viruses; Time Factors; Uveal Neoplasms; Virus Replication | 2012 |
Combined liver and pancreas resection with biochemotherapy for metastatic ocular melanoma.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Eye Enucleation; Female; Hepatectomy; Humans; Interferon-alpha; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Uveal Neoplasms | 2002 |
Effects of interferon-alpha, verapamil and dacarbazine in the treatment of advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Channel Blockers; Dacarbazine; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Recombinant Proteins; Remission Induction; Skin Neoplasms; Survival Rate; Treatment Outcome; Uveal Neoplasms; Verapamil | 2003 |
Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Fatal Outcome; Female; Follow-Up Studies; Hepatectomy; Humans; Injections, Intra-Arterial; Liver Neoplasms; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Time Factors; Uveal Neoplasms | 2005 |
Artesunate in the treatment of metastatic uveal melanoma--first experiences.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Artemisia; Artemisinins; Artesunate; Dacarbazine; Fatal Outcome; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Sesquiterpenes; Time Factors; Treatment Outcome; Uveal Neoplasms | 2005 |
Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.
Topics: Animals; Antigens, Neoplasm; Antigens, Polyomavirus Transforming; Dacarbazine; Fas Ligand Protein; Female; Immunohistochemistry; In Situ Hybridization; Male; Melanoma; Melanoma-Specific Antigens; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Proteins; Pigment Epithelium of Eye; S100 Proteins; Uveal Neoplasms | 1998 |